Sjøholt G

No ORCID on file · 1 paper in corpus
2019
Journal of cancer research and clinical oncology ·doi:10.1007/s00432-019-02931-1

PurposeValproic acid (VPA) is suggested to be therapeutically beneficial in combination with interferon-alpha (IFNα) in various cancers. Therefore, we examined IFNα and VPA alone and in combinations in selected AML models, examining immune …